Advanced search
Publication Cover
Personalized Medicine Volume 10, 2013 - Issue 4
Submit an article Journal homepage
995
Views
0
CrossRef citations to date
0
Altmetric
Perspective

How Could Disclosing Incidental Information from Whole-Genome Sequencing Affect Patient Behavior?

Kurt D Christensen1 Department of Medicine, Division of Genetics, Brigham&Women‘s Hospital&Harvard Medical School, EC Alumnae Hall, Suite 301, 41 Avenue Louis Pasteur, Boston, MA02115-5727, USACorrespondence[email protected]
&
Robert C Green1 Department of Medicine, Division of Genetics, Brigham&Women‘s Hospital&Harvard Medical School, EC Alumnae Hall, Suite 301, 41 Avenue Louis Pasteur, Boston, MA02115-5727, USA;2 Partners Healthcare Center for Personalized Genetic Medicine, Boston, MA, USA
Pages 377-386 | Published online: 06 Jun 2013

References

  • Lander ES . Initial impact of the sequencing of the human genome. Nature470(7333) , 187–197 (2011).
  • Gilissen C , HoischenA, BrunnerH, VeltmanJ. Unlocking Mendelian disease using exome sequencing. Genome Biol.12(9) , 228 (2011).
  • Wolf SM , LawrenzFP, NelsonCA et al. Managing incidental findings in human subjects research: analysis and recommendations. J. Law Med. Ethics 36(2) , 219–248 (2008).
  • Meacham MC , StarksH, BurkeW, EdwardsK. Researcher perspectives on disclosure of incidental findings in genetic research. J. Empir. Res. Hum. Res. Ethics5(3) , 31–41 (2010).
  • McBride CM , KoehlyLM, SandersonSC, KaphingstKA. The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? Annu. Rev. Public Health31(1) , 89–103 (2010).
  • Chao S , RobertsJS, MarteauTM, SillimanR, CupplesLA, GreenRC. Health behavior changes after genetic risk assessment for Alzheimer disease: the REVEAL study. Alzheimer Dis. Assoc. Disord.22(1) , 94–97 (2008).
  • Taylor DH , Cook-DeeganRM, HirakiS, RobertsJS, BlazerDG, GreenRC. Genetic testing for Alzheimer‘s and long-term care insurance. Health Aff.29(1) , 102–108 (2010).
  • de Viron S , van der Heyden J, Ambrosino E, Arbyn M, Brand A, Van Oyen H. Impact of genetic notification on smoking cessation: systematic review and pooled-analysis. PLoS ONE7(7) , e40230 (2012).
  • Bloss CS , SchorkNJ, TopolEJ. Effect of direct-to-consumer genome wide profiling to assess disease risk. N. Engl. J. Med.364(6) , 524–534 (2011).
  • Marteau TM , FrenchDP, GriffinSJ et al. Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst. Rev. 10 , CD007275 (2010).
  • Christensen KD , RobertsJS, UhlmannWR et al. How does pleiotropic information affect health behavior changes? Initial results from the REVEAL study, a randomized trial of genetic testing for Alzheimer‘s disease risk. Presented at: 2010 ACMG Annual Clinical Genetics Meeting. Albuquerque, NM, USA, 24–28 March 2010.
  • Christensen KD , RobertsJS, UhlmannWR et al. The psychological impact of learning about APOE–cardiovascular disease associations during genetic risk assessment for Alzheimer‘s disease: findings from the REVEAL study. Alzheimers Dement. 6(4 Suppl. 1) , S96–S96 (2010).
  • Green RC , BergJS, BerryGT et al. Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet. Med. 14(4) , 405–410 (2012).
  • Becker MH , JanzNK. Behavioral science perspectives on health hazard/health risk appraisal. Health Serv. Res.22(4) , 537–551 (1987).
  • Rosenstock IM . Historical origins of the health belief model. Health Educ. Monogr.2(4) , 328–335 (1974).
  • Matzger H , KaskutasLA, WeisnerC. Reasons for drinking less and their relationship to sustained remission from problem drinking. Addiction100(11) , 1637–1646 (2005).
  • West R , SohalT. ‘Catastrophic‘ pathways to smoking cessation: findings from national survey. BMJ332(7539) , 458–460 (2006).
  • Ferguson SG , ShiffmanS, GitchellJG, SembowerMA, WestR. Unplanned quit attempts – results from a US sample of smokers and ex-smokers. Nicotine Tob. Res.11(7) , 827–832 (2009).
  • Resnicow K , PageSE. Embracing chaos and complexity: a quantum change for public health. Am. J. Public Health98(8) , 1382–1389 (2008).
  • Fabsitz RR , McGuireA, SharpRR et al. Ethical and practical guidelines for reporting genetic research results to study participants. Circ. Cardiovasc. Genet. 3(6) , 574–580 (2010).
  • Downing NR , WilliamsJK, Daack-HirschS, DriessnackM, SimonCM. Genetics specialists‘ perspectives on disclosure of genomic incidental findings in the clinical setting. Patient Educ. Couns.90(1) , 133–138 (2013).
  • Wright C , BurtonH, HallA et al. Next Steps in the Sequence. The Implications of Whole Genome Sequencing for Health in the UK. PHG Foundation, Cambridge, UK (2011).
  • McGuire AL , LupskiJR. Personal genome research: what should the participant be told? Trends Genet.26(5) , 199–201 (2010).
  • Berg JS , KhouryMJ, EvansJP. Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet. Med.13(6) , 499–504 (2011).
  • Institute of Medicine. Integrating Large-Scale Genomic Information into Clinical Practice: Workshop Summary. The National Academies Press, Washington, DC, USA (2012).
  • Janz NK , BeckerMH. The health belief model: a decade later. Health Educ. Q.11(1) , 1–47 (1984).
  • Linnenbringer E , RobertsJS, HirakiS, CupplesLA, GreenRC. ‘I know what you told me, but this is what I think:‘ perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate. Genet. Med.12(4) , 219–227 (2010).
  • Audrain-Mcgovern J , HughesC, PattersonF. Effecting behavior change: awareness of family history. Am. J. Prev. Med.24(2) , 183–189 (2003).
  • Heshka JT , PalleschiC, HowleyH, WilsonB, WellsPS. A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet. Med.10(1) , 19–32 (2008).
  • Collins RE , WrightAJ, MarteauTM. Impact of communicating personalized genetic risk information on perceived control over the risk: a systematic review. Genet. Med.13(4) , 273–277 (2011).
  • Biesecker LG . Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project. Genet. Med.14(4) , 393–398 (2012).
  • Murphy J , ScottJ, KaufmanD, GellerG, LeroyL, HudsonK. Public expectations for return of results from large-cohort genetic research. Am. J. Bioeth.8(11) , 36–43 (2008).
  • Harris ED , ZinielSI, AmatrudaJG et al. The beliefs, motivations, and expectations of parents who have enrolled their children in a genetic biorepository. Genet. Med. 14(3) , 330–337 (2012).
  • Zikmund-Fisher BJ , AngottA, UbelP. The benefits of discussing adjuvant therapies one at a time instead of all at once. Breast Cancer Res. Treat.129(1) , 79–87 (2011).
  • Zikmund-Fisher BJ , FagerlinA, UbelPA. A demonstration of ‘less can be more‘ in risk graphics. Med. Decis. Making30(6) , 661–671 (2010).
  • Ruffin MT , NeaseDE Jr, Sen A et al. Effect of preventive messages tailored to family history on health behaviors: the family healthware impact trial. Ann. Fam. Med.9(1) , 3–11 (2011).
  • Petty RE , CacioppoJT. The elaboration likelihood model of persuasion. In: Advances in Experimental Social Psychology. Berkowitz L (Ed.). Academic Press, NY, USA, 124–205 (1986).
  • Ringold D . Boomerang effects in response to public health interventions: some unintended consequences in the alcoholic beverage market. J. Consumer Policy25(1) , 27–63 (2002).
  • Brehm JA . Theory of Psychological Reactance. John Wiley&Sons, CA, USA (1966).
  • Marteau TM , SeniorV, HumphriesSE et al. Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial. Am. J. Med. Genet. A 128A(3) , 285–293 (2004).
  • Richards M . Families, kinship and genetics. In: The Troubled Helix: Social and Psychological Implications of the New Human Genetics. Marteau T, Richards M (Eds). Cambridge University Press, Cambridge, NY, USA, 249–273 (1996).
  • Nelkin D , LindeeMS. The DNA Mystique: the Gene as a Cultural Icon. University of Michigan, MI, USA (2004).
  • Roberts JS . Surveying customer responses to personal genetic services. Presented at: The American Society of Human Genetics 62nd Annual Meeting. San Francisco, CA, USA, 6–10 November 2012.
  • Resnicow K , McMasterF. Motivational Interviewing: moving from why to how with autonomy support. Int. J. Behav. Nutr. Phys. Act.9(1) , 19 (2012).
  • Shiloh S . Illness representations, self-regulation, and genetic counseling: a theoretical review. J. Genet. Couns.15(5) , 325–337 (2006).
  • Baumeister RF . The self. In: The Handbook of Social Psychology. Gilbert DT, Fiske ST, Lindzey G (Eds). McGraw-Hill, NY, USA. 680–740 (1998).
  • Steele CM . The psychology of self-affirmation: sustaining the integrity of the self. In: Advances in Experimental Social Psychology. Berkowitz L (Ed.). Academic Press, CA, USA, 261–302 (1988).
  • Etchegary H , PerrierC. Information processing in the context of genetic risk: implications for genetic-risk communication. J. Genet. Couns.16(4) , 419–432 (2007).
  • Rochman B . Test your DNA for diseases – no doctor required. Time, 23rd October (2012).
  • Janssens AC , GwinnM, BradleyLA, OostraBA, van Duijn CM, Khoury MJ. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am. J. Hum. Genet.82(3) , 593–599 (2008).
  • Berg JS , AdamsM, NassarN et al. An informatics approach to analyzing the incidentalome. Genet. Med. 15(1) , 36–44 (2013).
  • Bankhead CR , BrettJ, BukachC et al. The impact of screening on future health-promoting behaviours and health beliefs: a systematic review. Health Technol. Assess. 7(42) , 1–92 (2003).
  • Strecher VJ , KreuterMW. The psychosocial and behavioral impact of health risk appraisals. In: Psychosocial Effects of Screening for Disease Prevention and Detection. Croyle RT (Ed.). Oxford University Press, NY, USA, 126–143 (1995).
  • McGuire AL , BurkeW. An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. JAMA300(22) , 2669–2671 (2008).
  • Secretary ‘s Advisory Committee on Genetics, Health and Society. Genetics Education and Training. Department of Health&Human Services, Washington, DC, USA (2011).
  • Suther S , GoodsonP. Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature. Genet. Med.5(2) , 70–76 (2003).
  • Archibald AD , HickertonCL, JaquesAM, WakeS, CohenJ, MetcalfeSA. ‘It‘s about having the choice‘: stakeholder perceptions of population-based genetic carrier screening for fragile X syndrome. Am. J. Med. Genet. A161(1) , 48–58 (2013).
  • Tarini BA . Storage and use of residual newborn screening blood spots: a public policy emergency. Genet. Med.13(7) , 619–620 (2011).
  • Roser MA . State sued over babies‘ blood. Austin American-Statesman, 13th March (2009).
  • Sangha KK , DircksA, LangloisS. Assessment of the effectiveness of genetic counseling by telephone compared with a clinic visit. J. Genet. Couns.12(2) , 171–184 (2003).
  • Witte K , AllenM. A meta-analysis of fear appeals: implications for effective public health campaigns. Health Educ. Behav.27(5) , 591–615 (2000).
  • McBride CM , CurrySJ, GrothausLC, RosnerD, LouieD, WagnerEH. Use of self-help materials and smoking cessation among proactively recruited and volunteer intervention participants. Am. J. Health Promot.12(5) , 321–324 (1998).
  • Tzelepis F , PaulCL, WalshRA, McElduffP, KnightJ. Proactive telephone counseling for smoking cessation: meta-analyses by recruitment channel and methodological quality. J. Natl Cancer Inst.103(12) , 922–941 (2011).
  • Christensen KD , RobertsJS, Zikmund-FisherBJ, KardiaSL, McbrideCM, GreenRC. Self-referral to genetic susceptibility testing for Alzheimer‘s disease: implications for uptake and responses to results. Presented at: The 2013 ACMG Annual Clinical Genetics Meeting. Phoenix, AZ, USA, 19–23 March 2013.
  • Manne S , FasanellaN, ConnorsJ, FloydB, WangH, LessinS. Sun protection and skin surveillance practices among relatives of patients with malignant melanoma: prevalence and predictors. Prev. Med.39(1) , 36–47 (2004).
  • Berwick M , BeggCB, FineJA, RoushGC, BarnhillRL. Screening for cutaneous melanoma by skin self-examination. J. Natl Cancer Inst.88(1) , 17–23 (1996).
  • Kohane IS , HsingM, KongSW. Taxonomizing, sizing, and overcoming the incidentalome. Genet. Med.14(4) , 399–404 (2012).
  • Rew L , KaurM, McMillanA, MackertM, BonevacD. Systematic review of psychosocial benefits and harms of genetic testing. Issues Ment. Health Nurs.31(10) , 631–645 (2010).
  • Green RC , RobertsJS, CupplesLA et al. Disclosure of APOE genotype for risk of Alzheimer‘s disease. N. Engl. J. Med. 361(3) , 245–254 (2009).
  • Witte K . Putting the fear back into fear appeals: the extended parallel process model. Commun. Monogr.59(4) , 329–349 (1992).
  • Eichler EE , FlintJ, GibsonG et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat. Rev. Genet. 11(6) , 446–450 (2010).
  • McBride CM , BryanAD, BrayMS, SwanGE, GreenED. Health behavior change: can genomics improve behavioral adherence? Am. J. Public Health102(3) , 401–405 (2012).
  • Colditz GA , WeiEK. Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. Annu. Rev. Public Health33(1) , 137–156 (2012).
  • Beery TA , WilliamsJK. Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders. Genet. Test.11(2) , 111–123 (2007).
  • Kasparian NA , MeiserB, ButowPN, SimpsonJM, MannGJ. Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families. Genet. Med.11(4) , 265–278 (2009).
  • Grant RW , O‘BrienKE, WaxlerJL et al. Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial. Diabetes Care 36(1) , 13–19 (2013).
  • Morris JC . Dementia update 2005. Alzheimer Dis. Assoc. Disord.19(2) , 100–117 (2005).
  • Alamian A , RouleauI, SimardJ, DorvalM. Use of dietary supplements among women at high risk of Hereditary Breast and Ovarian Cancer (HBOC) tested for cancer susceptibility. Nutr. Cancer54(2) , 157–165 (2006).
  • Vernarelli JA , RobertsJS, HirakiS, ChenCA, CupplesLA, GreenRC. Effect of Alzheimer disease genetic risk disclosure on dietary supplement use. Am. J. Clin. Nutr.91(5) , 1402–1407 (2010).
  • The President‘s Council on Bioethics. The Changing Moral Focus of Newborn Screening: an Ethical Analysis by the President‘s Council on Bioethics. The President‘s Council on Bioethics, Washington, DC, USA (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.